NCT Number: NCT00115713
Effects of Aerobic Exercise Versus Weight Training in Breast Cancer Survivors During Chemotherapy
The purpose of this study is to compare the effects of two different types of exercise, aerobic exercise training (AET) and resistance exercise training (RET), on quality of life (QoL) in early stage breast cancer survivors receiving chemotherapy. It is hypothesized that both AET and RET would have beneficial effects on QoL.
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
Female
Study type
Interventional
Phase
Phase 3
Primary location
University of Alberta, Edmonton, Alberta, Canada
About this study
The study was a prospective, three-armed, randomized controlled trial. Participants were stratified by site (Edmonton, Ottawa, and Vancouver) and planned chemotherapy protocol (taxane-based versus nontaxane-based) and randomly assigned to AET, RET, or usual care (UC) in a 1:1:1 ratio using a random-numbers table. Participants assigned to the AET group were asked to perform aerobic exercise three times per week on a recumbent or upright cycle ergometer, treadmill, or elliptical. Exercise duration began at 15 minutes for weeks 0 through 2, and then systematically increased by 5 minutes every three weeks thereafter to 45 minutes for weeks 18 and beyond. Exercise intensity began at 60% of VO2max for weeks 0 through 2 and then systematically increased by 10% every 6 weeks thereafter to 80% of VO2max for weeks 12 and beyond. Warm-up and cool-down periods consisted of 5 minutes of aerobic activity at the power output of the ventilatory equivalent for oxygen (approximately 50% of peak oxygen consumption). Participants assigned to the RET group were asked to perform resistance exercise three times per week, which consisted of two sets of 10 repetitions of 9 different exercises performed at 60-70% of 1-repetition maximum. The specific exercises were: leg extension, leg curl, calf raises, chest press, latissimus pulldown, overhead press, triceps extension, biceps curls, and modified curl-ups. Resistance was increased by approximately 10% or the next weight level when the participant was able to complete 12 repetitions per set without difficulty.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Breast cancer early stage I -IIIA
- Completed axillary surgery
- Scheduled to receive adjuvant chemotherapy for 9 - 24 weeks
- Approval of the treating oncologist
- Able to understand and provide written informed consent in English or French (Ottawa)
- 18+ years of age
- No uncontrolled hypertension, cardiac illness, psychiatric condition
- No contraindication to exercise as determined by a fitness test
Exclusion criteria
- Pregnant.
- Unwilling to accept randomization.
- Any medical condition that would be a contraindication to exercise. The clinicians will make this decision.
- Unwilling to travel to/participate in the exercise program as defined by the protocol.
- Previous chemotherapy (previous cancer is NOT an exclusion criteria).
- Cancer recurrence.
- Planned/known absence of greater than 2 weeks during the intended study period.
- Previous therapy for known breast cancer.
- Those who have had TRAM (i.e., Transabdominal Rectus Abdominus Muscle Reconstructive Surgery) done.
- Moderate lymphedema (>20% or >200mL difference between the affected arm and the unaffected arm).
Treatment and study plan
Resistance Exercise Training
BehavioralPrimary outcomes
-
Quality of Life
Secondary outcomes
-
Physical Fitness
-
Body Composition
-
Lymphedema
-
Treatment Completion Rates
-
Selected Biomarkers
-
Exercise Adherence Rates and Determinants
Sponsors and collaborators
Lead sponsor
University of Alberta
Other
Collaborators
- Canadian Breast Cancer Research Alliance
Registry information
Official study title
Comparison of Aerobic Versus Resistance Exercise Training in Enhancing Quality of Life in Early Stage Breast Cancer Survivors Receiving Chemotherapy: A Multi-Centre Randomized Trial
Important dates
- Study start
- 2003
- Study completion
- 2005
- First posted
- Jun 24, 2005
- Registry last updated
- Nov 5, 2024
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
BRCA Mutations in Latinas
NCT01251900
Breast Diseases, Breast Neoplasms
Lubbock, Texas, United States
View Trial DetailsLifestyle, Exercise, and Nutrition Study Early After Diagnosis
NCT03314688
Breast Diseases, Breast Neoplasms
New Haven, Connecticut, United States
View Trial DetailsA Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer
NCT04572295
Acrocephalosyndactylia, Bone Diseases
Nagoya, Aichi-ken, Japan
View Trial DetailsA Study to Understand About the Study Medicine Palbociclib in Breast Cancer Patients After it is Out in the Japanese Market
NCT07096024
Breast Diseases, Breast Neoplasms
New York, United States
View Trial Details